Trials in Progress from the ASCO 2025 Annual Meeting
This interactive dashboard visualizes 385 clinical trials in progress (TPS abstracts) reported at ASCO 2025. These represent the future of cancer treatment, featuring ongoing studies across multiple cancer types and novel therapeutic approaches. Each data point represents a trial currently enrolling or in development, providing insights into the clinical research pipeline across 12 different cancer tracks spanning from early-phase exploratory studies to large confirmatory trials.
Note: This data is extracted from ASCO 2025 abstracts by homepage, X) using LLMs. Please report any data quality issues to spiff007@{free email service from Google}.
(All data is the copyright of ASCO, ยฉASCO. It is visualized here to be useful to the cancer research community.
This comprehensive dataset represents the cutting edge of cancer research, spanning 385 ongoing clinical trials across 12 distinct cancer tracks. The studies showcase breakthrough approaches including CAR-T cell therapies, antibody-drug conjugates (ADCs), next-generation checkpoint inhibitors, and innovative precision medicine strategies. With enrollment targets ranging from small Phase 1 dose-escalation studies of 12 patients to large confirmatory trials of 1149 participants (average: 116 patients per study), these investigations collectively represent billions of dollars in research investment and the therapeutic pipeline for millions of cancer patients worldwide. The dominance of developmental therapeutics (86 studies), lung cancer (51 studies), and breast cancer (49 studies) reflects both urgent unmet medical needs and significant recent advances in our molecular understanding of these diseases. The 165 early-phase trials (43% of all studies) demonstrate the experimental nature of this pipeline, featuring 167 distinct investigational agents from 38 companies worldwide.
Hybrid search: keywords + TF-IDF semantic similarity + concept groups - try complex queries like medical abbreviations, drug names, or specific cancer types
Search for a specific trial by TPS ID. Enter just the number (e.g., 2088 for TPS2088). Found trial will be displayed alone on the plot.
The trials shown above are from ASCO 2025 "Trials in Progress" (TPS) abstracts. These represent ongoing clinical studies that are actively enrolling patients or in development phases. Unlike completed trial results, TPS abstracts provide insights into the future pipeline of cancer therapeutics and research directions. This dashboard helps researchers, clinicians, and patients understand what treatments are being developed and tested across different cancer types.